Ning Li

机构：Xinjiang Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, First Affiliated Hospital of Xinjiang Medical University, National Cancer Center, Shanxi Provincial Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Hangzhou First People's Hospital, Innovative Research (United States), Ningbo First Hospital · ORCID：0000-0002-3945-2536

发表论文 300 篇 · 总被引 4813 次 · h-index 33

代表论文

• Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy (2025 · Med · 被引 17)
• Watershed year of cell and gene therapy (CGT): A review of 2024 CGT approvals (2025 · Cancer Letters · 被引 5)
• Beyond TIGIT: Lessons from a failed immune checkpoint for rational target discovery (2025 · Med · 被引 2)
• Assessing the Impact of CDR Deamidation and Isomerization on mAb Target Binding Using Affinity-Resolved 2D-SEC-SCX-MS Analysis (2025 · Journal of the American Society for Mass Spectrometry · 被引 2)
• Red Blood Cell‐Derived Exosomal miR‐93‐5p Promotes Lung Cancer Progression through PTEN Suppression (2025 · Advanced Science · 被引 2)
• An Online Buffer Exchange Platform for Charge Detection Mass Spectrometry Analysis of AAVs and AAV-Antibody Complexes (2025 · Journal of the American Society for Mass Spectrometry · 被引 2)